Why People with Lupus Must be More Careful Amid COVID-19 News and Stories June 16, 2020 June 9, 2020 This may be hard to believe--since we are currently so immersed in the current pandemic—but COVID-19 and...
FDA Revoked Emergency Use Approval of Hydroxychloroquine for COVID-19 News and Stories June 15, 2020 The U.S. Food and Drug Administration announced June 15 that it revoked approval called emergency use authorization...
LRA-Funded Findings Suggest Way to Help Reverse Lupus Nephritis News and Stories June 15, 2020 A recently published study explored how an unconventional treatment method undergoing clinical trials in cancer patients could...
New Guidelines from the ACR For Lupus Care During COVID-19 Pandemic News and Stories June 9, 2020 The American College of Rheumatology enlisted 14 experts on infectious diseases and immune system illnesses to develop...
A Message From LRA President & Ceo on COVID-19 and Lupus News and Stories These are challenging times for everyone-and each of us must stay focused. For the Lupus Research Alliance (LRA) this...
Watch Video of Webcast: Lupus and Cognitive Health News and Stories Watch a videotape of our recent webcast: Lupus and Cognitive Health Presented by LRA’s Young Leaders Board People with lupus know...
Promising News from Major Medical Meeting, EULAR News and Stories Updated June 5, 2020 One of the largest meetings for rheumatologists went virtual this year to enable scientists from around...
Lupus Research Alliance Issues Statement June 4, 2020 News and Stories June 4, 2020 Racism, bigotry, intolerance and violence are hateful and have no place in American society. The Lupus Research Alliance...
Positive Data from Trial of Investigational Treatment KZR-616 for Lupus and Lupus Nephritis News and Stories June 3, 2020 Kezar Life Sciences, Inc. today announced updated results from the Phase 1b (Ph1b) portion of MISSION, a...
LRA Congratulates AstraZeneca on Positive Data on Anifrolumab Presented at Major Medical Meeting News and Stories June 3, 2020 The Lupus Research Alliance (LRA) is encouraged by positive data from two studies presented at the European...
Aurinia Completes NDA and Requests Priority Review of Voclosoporin by FDA for Lupus Nephritis News and Stories May 28, 2020 May 28, 2020 The Lupus Research Alliance is pleased to share that Aurinia Pharmaceuticals Inc submitted a New Drug Application...
Lupus and COVID-19: What You Need to Know – LIVE WEBCAST May 21 at 6 PM ET News and Stories Since the arrival of the novel coronavirus, lupus and the most prescribed drug used to treat it – hydroxychloroquine...